163 related articles for article (PubMed ID: 36445385)
1. Verapamil inhibits Kir2.3 channels by binding to the pore and interfering with PIP
Xynogalos P; Rahm AK; Fried S; Chasan S; Scherer D; Seyler C; Katus HA; Frey N; Zitron E
Naunyn Schmiedebergs Arch Pharmacol; 2023 Apr; 396(4):659-667. PubMed ID: 36445385
[TBL] [Abstract][Full Text] [Related]
2. Dual Mechanism for Inhibition of Inwardly Rectifying Kir2.x Channels by Quinidine Involving Direct Pore Block and PIP
Koepple C; Scherer D; Seyler C; Scholz E; Thomas D; Katus HA; Zitron E
J Pharmacol Exp Ther; 2017 May; 361(2):209-218. PubMed ID: 28188270
[TBL] [Abstract][Full Text] [Related]
3. Class III antiarrhythmic drug dronedarone inhibits cardiac inwardly rectifying Kir2.1 channels through binding at residue E224.
Xynogalos P; Seyler C; Scherer D; Koepple C; Scholz EP; Thomas D; Katus HA; Zitron E
Naunyn Schmiedebergs Arch Pharmacol; 2014 Dec; 387(12):1153-61. PubMed ID: 25182566
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of inwardly rectifying Kir2.x channels by the novel anti-cancer agent gambogic acid depends on both pore block and PIP
Scherer D; Schworm B; Seyler C; Xynogalos P; Scholz EP; Thomas D; Katus HA; Zitron E
Naunyn Schmiedebergs Arch Pharmacol; 2017 Jul; 390(7):701-710. PubMed ID: 28365825
[TBL] [Abstract][Full Text] [Related]
5. Propafenone blocks human cardiac Kir2.x channels by decreasing the negative electrostatic charge in the cytoplasmic pore.
Amorós I; Dolz-Gaitón P; Gómez R; Matamoros M; Barana A; de la Fuente MG; Núñez M; Pérez-Hernández M; Moraleda I; Gálvez E; Iriepa I; Tamargo J; Caballero R; Delpón E
Biochem Pharmacol; 2013 Jul; 86(2):267-78. PubMed ID: 23648307
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of Cardiac Kir Current (IK1) by Protein Kinase C Critically Depends on PKCβ and Kir2.2.
Scherer D; Seyler C; Xynogalos P; Scholz EP; Thomas D; Backs J; Andrassy M; Völkers M; Karle CA; Katus HA; Zitron E
PLoS One; 2016; 11(5):e0156181. PubMed ID: 27214373
[TBL] [Abstract][Full Text] [Related]
7. Long polyamines act as cofactors in PIP2 activation of inward rectifier potassium (Kir2.1) channels.
Xie LH; John SA; Ribalet B; Weiss JN
J Gen Physiol; 2005 Dec; 126(6):541-9. PubMed ID: 16316973
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the effects of antiarrhythmic drugs flecainide and verapamil on fKv1.4ΔN channel currents in Xenopus oocytes.
Chen H; Zhang D; Chao SP; Ren JH; Xu L; Jiang XJ; Wang SM
Acta Pharmacol Sin; 2013 Feb; 34(2):221-30. PubMed ID: 23202797
[TBL] [Abstract][Full Text] [Related]
9. Role of plasma membrane-associated AKAPs for the regulation of cardiac I
Seyler C; Scherer D; Köpple C; Kulzer M; Korkmaz S; Xynogalos P; Thomas D; Kaya Z; Scholz E; Backs J; Karle C; Katus HA; Zitron E
Naunyn Schmiedebergs Arch Pharmacol; 2017 May; 390(5):493-503. PubMed ID: 28331977
[TBL] [Abstract][Full Text] [Related]
10. Regulation of cardiac inwardly rectifying potassium current IK1 and Kir2.x channels by endothelin-1.
Kiesecker C; Zitron E; Scherer D; Lueck S; Bloehs R; Scholz EP; Pirot M; Kathöfer S; Thomas D; Kreye VA; Kiehn J; Borst MM; Katus HA; Schoels W; Karle CA
J Mol Med (Berl); 2006 Jan; 84(1):46-56. PubMed ID: 16258766
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms for Kir channel inhibition by quinacrine: acute pore block of Kir2.x channels and interference in PIP2 interaction with Kir2.x and Kir6.2 channels.
López-Izquierdo A; Aréchiga-Figueroa IA; Moreno-Galindo EG; Ponce-Balbuena D; Rodríguez-Martínez M; Ferrer-Villada T; Rodríguez-Menchaca AA; van der Heyden MA; Sánchez-Chapula JA
Pflugers Arch; 2011 Oct; 462(4):505-17. PubMed ID: 21779761
[TBL] [Abstract][Full Text] [Related]
12. Electrophysiological and Pharmacological Characterization of Human Inwardly Rectifying K
Sanson C; Schombert B; Filoche-Rommé B; Partiseti M; Bohme GA
Assay Drug Dev Technol; 2019 Apr; 17(3):89-99. PubMed ID: 30835490
[TBL] [Abstract][Full Text] [Related]
13. Structural basis of drugs that increase cardiac inward rectifier Kir2.1 currents.
Gómez R; Caballero R; Barana A; Amorós I; De Palm SH; Matamoros M; Núñez M; Pérez-Hernández M; Iriepa I; Tamargo J; Delpón E
Cardiovasc Res; 2014 Nov; 104(2):337-46. PubMed ID: 25205296
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of block and identification of the verapamil binding domain to HERG potassium channels.
Zhang S; Zhou Z; Gong Q; Makielski JC; January CT
Circ Res; 1999 May; 84(9):989-98. PubMed ID: 10325236
[TBL] [Abstract][Full Text] [Related]
15. Effect of extracellular cations on the inward rectifying K+ channels Kir2.1 and Kir3.1/Kir3.4.
Owen JM; Quinn CC; Leach R; Findlay JB; Boyett MR
Exp Physiol; 1999 May; 84(3):471-88. PubMed ID: 10362846
[TBL] [Abstract][Full Text] [Related]
16. The IK1/Kir2.1 channel agonist zacopride prevents and cures acute ischemic arrhythmias in the rat.
Zhai XW; Zhang L; Guo YF; Yang Y; Wang DM; Zhang Y; Li P; Niu YF; Feng QL; Wu BW; Cao JM; Liu QH
PLoS One; 2017; 12(5):e0177600. PubMed ID: 28542320
[TBL] [Abstract][Full Text] [Related]
17. Hydrogen sulfide inhibits Kir2 and Kir3 channels by decreasing sensitivity to the phospholipid phosphatidylinositol 4,5-bisphosphate (PIP
Ha J; Xu Y; Kawano T; Hendon T; Baki L; Garai S; Papapetropoulos A; Thakur GA; Plant LD; Logothetis DE
J Biol Chem; 2018 Mar; 293(10):3546-3561. PubMed ID: 29317494
[TBL] [Abstract][Full Text] [Related]
18. Effect of verapamil enantiomers and metabolites on cardiac K+ channels expressed in Xenopus oocytes.
Waldegger S; Niemeyer G; Mörike K; Wagner CA; Suessbrich H; Busch AE; Lang F; Eichelbaum M
Cell Physiol Biochem; 1999; 9(2):81-9. PubMed ID: 10394001
[TBL] [Abstract][Full Text] [Related]
19. Andersen-Tawil Syndrome Is Associated With Impaired PIP
Handklo-Jamal R; Meisel E; Yakubovich D; Vysochek L; Beinart R; Glikson M; McMullen JR; Dascal N; Nof E; Oz S
Front Pharmacol; 2020; 11():672. PubMed ID: 32499698
[TBL] [Abstract][Full Text] [Related]
20. Activation of inwardly rectifying Kir2.x potassium channels by beta 3-adrenoceptors is mediated via different signaling pathways with a predominant role of PKC for Kir2.1 and of PKA for Kir2.2.
Scherer D; Kiesecker C; Kulzer M; Günth M; Scholz EP; Kathöfer S; Thomas D; Maurer M; Kreuzer J; Bauer A; Katus HA; Karle CA; Zitron E
Naunyn Schmiedebergs Arch Pharmacol; 2007 Jul; 375(5):311-22. PubMed ID: 17534603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
